Cargando…
Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair
Cell therapy for Parkinson’s disease (PD) is aimed to replace the degenerated midbrain dopamine (mDA) neurons and restore DA neurotransmission in the denervated forebrain targets. A limitation of the intrastriatal grafting approach, which is currently used in clinical trials, is that the mDA neurons...
Autores principales: | Björklund, Anders, Parmar, Malin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543294/ https://www.ncbi.nlm.nih.gov/pubmed/33814467 http://dx.doi.org/10.3233/JPD-212609 |
Ejemplares similares
-
Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective
por: Björklund, Anders, et al.
Publicado: (2020) -
Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies
por: Henchcliffe, Claire, et al.
Publicado: (2018) -
Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
por: Björklund, Anders, et al.
Publicado: (2017) -
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
por: Björklund, Anders, et al.
Publicado: (2022) -
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson’s Disease
por: Adler, Andrew F., et al.
Publicado: (2019)